Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02240329 · ClinicalTrials.gov registry record · Early Phase 1
Assessment of Dystussia in Traumatic Brain Injury
A Early Phase 1 study, sponsored by University of Florida.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 4
- Enrollment target
NCT02240329 is a Early Phase 1 study that has completed, run by University of Florida. The registered enrollment target is 4 participants.
The verdict
NCT02240329, a Early Phase 1 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this research study is to evaluate coughing in people who have had a brain injury. It is hypothesized that individuals who have sustained a brain injury will demonstrate differences in cough waveform and respiratory measures compared to individuals who have not sustained a brain injury.
Interventions
- BEHAVIORAL Neuropsychological Testing and Measures of TBI severity
- BEHAVIORAL Respiratory measures
- DRUG Capsaicin cough sensitivity testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2013-03 |
| Est. Completion | 2015-06 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02240329
The ClinicalTrials.gov registry entry for NCT02240329 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Neuropsychological Testing and Measures of TBI severity is the first listed.
NCT02240329 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02240329 about?
NCT02240329 is a clinical study titled "Assessment of Dystussia in Traumatic Brain Injury". The purpose of this research study is to evaluate coughing in people who have had a brain injury. It is hypothesized that individuals who have sustained a brain injury will demonstrate differences in cough waveform and respiratory measures compared to individuals who have not sustained a brain injur...
What is the current status of trial NCT02240329?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 4 participants. The study started on 2013-03. Estimated completion is 2015-06.
What interventions are being tested in trial NCT02240329?
The interventions under investigation include: Neuropsychological Testing and Measures of TBI severity (BEHAVIORAL), Respiratory measures (BEHAVIORAL), Capsaicin cough sensitivity testing (DRUG).
Who is sponsoring clinical trial NCT02240329?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.